![PDF) Oral Isobutyramide Therapy in Patients with Thalassemia Intermedia: Results of a Phase II Open Study PDF) Oral Isobutyramide Therapy in Patients with Thalassemia Intermedia: Results of a Phase II Open Study](https://i1.rgstatic.net/publication/12543581_Oral_Isobutyramide_Therapy_in_Patients_with_Thalassemia_Intermedia_Results_of_a_Phase_II_Open_Study/links/5bed467b299bf1124fd39300/largepreview.png)
PDF) Oral Isobutyramide Therapy in Patients with Thalassemia Intermedia: Results of a Phase II Open Study
Treatment of hepatitis C virus infection with directâ•'acting antiviral drugs is safe and effective in patients with hemogl
![Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent. Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.](https://data08.123doks.com/thumbv2/123dokorg/000/212/212363/cover.webp)
Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent.
chain rebalance -thalassemia patient cells restoring HbA production and β IVS2-745 2'-O-methoxyethyl splice-switching oligos co
![PDF) Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients | Alberto Roghi and Angela Milazzo - Academia.edu PDF) Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients | Alberto Roghi and Angela Milazzo - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/43304531/mini_magick20190216-9448-kgql9r.png?1550331171)